Press Release

PathoQuest Secures 8 Million Euros in New Financing
PathoQuest Secures 8 Million Euros in New Financing

PathoQuest, announced that it has received GLP certificate of conformity following a successful inspection by the French National Agency for Medicine and Health Products Safety (ANSM). PathoQuest is the first company in France to receive such a certificate from the ANSM for NGS viral safety testing. (“high-throughput sequencing detection of incidental replicative virus test in eukaryote cells”).

read more
PathoQuest announces enrollment of first patient in IDENTIFY, a prospective clinical study assessing the medico-economic benefit of iDTECT™ Blood for the diagnosis of bloodstream infection in immunocompromised patients

Press ReleasePARIS, FRANCE, May 22, 2018 – PathoQuest, a genomic expert for biologics testing and a leader in improving pathogen identification in clinical biological samples, today announced the initiation and enrollment of the first patient in a medico-economic...

read more

Click here to learn more about PathoQuest’s Biologics Genomic Service for biopharmaceutical companies.

Connect

 

EnglishFrenchGermanSpanish